maritide obesity drug news - Search News

Amgen says obesity drug caused up to 20% weight loss

Newsweek on MSN · 16h

Amgen Obesity Drug More Effective Than Competitors

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

BioPharma Dive · 2d

Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.

CNBC on MSN · 2d

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Amgen's big reveal of obesity data falls a bit flat

William Blair's assessment is that MariTide is an improvement on current obesity therapies with a profile that "will be ...

2d

Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations

The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...

Investor's Business Daily on MSN2d

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results